Benchmark lowered the firm’s price target on Harvard Bioscience (HBIO) to $4.50 from $5.50 and keeps a Speculative Buy rating on the shares. End-user markets in biomedical research continue to ...
Rebranding efforts include a new logo, overall brand presence, and corporate design.
After hours: March 26 at 4:05:10 PM EDT Loading Chart for LEXX ...
After hours: March 24 at 4:11:32 PM EDT Loading Chart for DARE ...
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback